Laboratory blood test profiling reveals distinct biochemical and hemocyte features of KRAS mutated non-small cell lung cancer

BACKGROUND: The testing for capability of some routine blood test parameters to reflect the biology of non-small cell lung carcinoma with different driver mutations is of great interest and practice significance. We aim to screen these variables and, if allowed, develop a novel predictive model base...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Limin, Cai, Xiuyu, Zeng, Wenchuang, Huang, Liyan, Deng, Qiuhua, Tang, Hailing, Chen, Zhuxing, Zhou, Huan, Lin, Yongping, Liu, Liping, Liang, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992621/
https://www.ncbi.nlm.nih.gov/pubmed/36910115
http://dx.doi.org/10.21037/jtd-22-829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9992621/
https://www.ncbi.nlm.nih.gov/pubmed/36910115
http://dx.doi.org/10.21037/jtd-22-829

Ejemplares similares